Input | Base case estimate | Distribution | Distribution parameter(s) |
---|---|---|---|
eConsult | Â | Â | Â |
Transition probabilities (%) | Â | Â | Â |
New patient | 96.2% | Beta | ɑ: 125; β:5 |
DNA face to face attendances | 6% | Beta | ɑ: 6; β:94 |
Subsequent face to face attendance | Â | Â | Â |
New patients | 15.2% | Beta | ɑ: 19; β:106 |
Review patients | 14.3% | Beta | ɑ: 1; β:6 |
Time for eConsult | Â | Â | Â |
Administration (min) | Â | Â | Â |
New patient | 20 | Gamma | É‘: 16.00; Æ›:0.8 |
Review patient | 10 | Gamma | É‘: 16.00; Æ›:1.6 |
Specialist time (min) | Â | Â | Â |
- Subsequent face to face attendance | Â | Â | Â |
New patient | 16.32 | Gamma | É‘: 1.60; Æ›:0.09 |
Review patient | 8.00 | Gamma | É‘: 1.78; Æ›:0.22 |
- No subsequent face to face attendance | Â | Â | Â |
New patient | 28.82 | Gamma | É‘: 2.71; Æ›:0.09 |
Review patient | 13.00 | Gamma | É‘: 22.53; Æ›:1.73 |
Cost for staff ($/min) | Â | Â | Â |
Administration officer | 0.72 | Normal | µ: 0.72;σ: 0.07 |
Specialist | 3.59 | Normal | µ: 3.59;σ: 0.36 |
Subsequent outpatient clinic cost | Â | Â | Â |
Scale relative to traditional pathway | 1.00 | Normal | µ: 1.00; σ: 0.25 |
Traditional | Â | Â | Â |
Transition probabilities (%) | Â | Â | Â |
Face to face attendance | Â | Â | Â |
New patient | 77.9% | Beta | ɑ: 106; β:30 |
Review patient | 84.9% | Beta | ɑ: 1; β:28 |
Video attendance | Â | Â | Â |
New patient | 6.7% | Beta | ɑ: 298; β:53 |
Review patient | 7.5% | Beta | ɑ: 4; β:49 |
Outpatient clinic cost | Â | Â | Â |
Face to face | Â | Â | Â |
New patient | 638.50 | Gamma | É‘: 3.835; Æ›:0.006 |
Review patient | 319.69 | Gamma | É‘: 2.629; Æ›:0.008 |
Video | Â | Â | Â |
New Patient | 574.75 | Gamma | É‘: 1.061; Æ›:0.002 |
Review patient | 276.07 | Gamma | É‘: 2.075; Æ›:0.008 |
Telephone | Â | Â | Â |
New patient | 282.61 | Gamma | É‘: 2.439; Æ›:0.008 |
Review patient | 239.47 | Gamma | É‘: 2.821; Æ›:0.012 |